Daniela Caldirola
Overview
Explore the profile of Daniela Caldirola including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
74
Citations
542
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Caldirola D, Dacco S, Cuniberti F, Grassi M, Alciati A, Torti T, et al.
J Affect Disord
. 2022 Apr;
310:75-86.
PMID: 35489559
Background: This study longitudinally evaluated first-onset major depression rates during the pandemic in Italian adults without any current clinician-diagnosed psychiatric disorder and created a predictive machine learning model (MLM) to...
12.
Caldirola D, Cuniberti F, Dacco S, Grassi M, Torti T, Perna G
J Neuropsychiatry Clin Neurosci
. 2022 Mar;
34(3):233-246.
PMID: 35306830
Objective: The investigators estimated new-onset psychiatric disorders (PsyDs) throughout the COVID-19 pandemic in Italian adults without preexisting PsyDs and developed a machine learning (ML) model predictive of at least one...
13.
Grassi M, Rickelt J, Caldirola D, Eikelenboom M, van Oppen P, Dumontier M, et al.
J Affect Disord
. 2021 Oct;
296:117-125.
PMID: 34600172
Introduction: The course of OCD differs widely among OCD patients, varying from chronic symptoms to full remission. No tools for individual prediction of OCD remission are currently available. This study...
14.
Caldirola D, Dacco S, Cuniberti F, Grassi M, Lorusso S, Diaferia G, et al.
J Psychosom Res
. 2021 Sep;
150:110604.
PMID: 34521061
Objective: We addressed elevated C-reactive protein level (eCRP) specificity comparing, for the first time, eCRP (i.e., serum CRP > 3 and ≤10 mg/L) in patients with major depressive disorder (MDD),...
15.
Dal Buono A, Caldirola D, Allocca M
Expert Rev Clin Immunol
. 2021 May;
17(8):803-806.
PMID: 34047240
No abstract available.
16.
Caldirola D, Alciati A, Cuniberti F, Perna G
J Exp Pharmacol
. 2021 Apr;
13:441-459.
PMID: 33889031
Several effective pharmacological therapies for panic disorder (PD) are available, but they have some drawbacks, and unsatisfactory outcomes can occur. Expanding the variety of anti-panic medications may allow for improving...
17.
Perna G, Dacco S, Alciati A, Cuniberti F, de Berardis D, Caldirola D
Prog Neuropsychopharmacol Biol Psychiatry
. 2020 Dec;
107:110208.
PMID: 33338557
Childhood maltreatment (CM) is a predictor of poor outcome across treatments for major depressive disorder (MDD), while its potential role as a predictor of differential responses to specific antidepressants has...
18.
Alciati A, Atzeni F, Caldirola D, Perna G, Sarzi-Puttini P
J Clin Med
. 2020 Nov;
9(11).
PMID: 33182759
About half of the patients with fibromyalgia (FM) had a lifetime major depression episode and one third had a panic disorder (PD). Because the co-morbidity between bipolar disorder (BD) and...
19.
Perna G, Cuniberti F, Dacco S, Nobile M, Caldirola D
J Affect Disord
. 2020 Oct;
277:772-778.
PMID: 33065816
Background: The wearing of respiratory protective devices (RPDs) correctly and continually in situations where people are at risk of respiratory infections is crucial for infection prevention. Certain people are poorly...
20.
Perna G, Cuniberti F, Dacco S, Grassi M, Caldirola D
Fortschr Neurol Psychiatr
. 2020 Aug;
88(12):759-766.
PMID: 32838431
Due to the increased lifetime prevalence and personal, social, and economic burden of mental disorders, psychiatry is in need of a significant change in several aspects of its clinical and...